Alpha Cognition Inc
ACOG - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$129.53M
Close$
$4.41
51.9% downside
Current Fair Value
51.9% downsideOvervalued by 51.9% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $129.53 Million |
|---|---|
| Enterprise Value | $88.25 Million |
| Earnings per Share | $-1.17 |
| Beta | 2.23 |
| Outstanding Shares | 21,774,104 |
Return
| Return on Equity | -44.26% |
|---|---|
| Return on Assets | -36.33% |
| Return on Invested Capital | -47.61% |
Valuation & Multiples
| P/E Ratio | -7.64 |
|---|---|
| PEG | 47.16 |
| Price to Sales | - |
| Price to Book Ratio | 4.59 |
| Enterprise Value to Revenue | 5.78 |
| Enterprise Value to EBIT | -3.19 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
$-0.39
Consensus analyst estimateRevenue Estimate
$4.38 M
Consensus analyst estimateNext Earnings Call
Expected Date
November 12, 2026
EPS Estimate
$-0.33
Consensus analyst estimateRevenue Estimate
$7.04 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 48.17%▼ 0.23% |
|---|---|
| Total Invested | $75.73M▲ 30.97% |
| Investors Holding | 26▲ 1.00% |
About Alpha Cognition Inc
71 employees
CEO: Michael E. McFadden
Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUN...